Edita Žiginskienė

1.3k total citations
25 papers, 139 citations indexed

About

Edita Žiginskienė is a scholar working on Nephrology, Epidemiology and Hematology. According to data from OpenAlex, Edita Žiginskienė has authored 25 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 5 papers in Epidemiology and 5 papers in Hematology. Recurrent topics in Edita Žiginskienė's work include Dialysis and Renal Disease Management (9 papers), Parathyroid Disorders and Treatments (5 papers) and Chronic Disease Management Strategies (4 papers). Edita Žiginskienė is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Parathyroid Disorders and Treatments (5 papers) and Chronic Disease Management Strategies (4 papers). Edita Žiginskienė collaborates with scholars based in Lithuania and Austria. Edita Žiginskienė's co-authors include Inga Arūnė Bumblytė, Asta Stankuvienė, Kristina Petrulienė, Irena Nedzelskienė, Eglė Ereminienė, Rūta Žvirblytė, Agnė Adukauskaitė, Leonas Valius, S. Gražulis and Brigita Šitkauskienė and has published in prestigious journals such as Nephrology Dialysis Transplantation, The Scientific World JOURNAL and Microorganisms.

In The Last Decade

Edita Žiginskienė

20 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edita Žiginskienė Lithuania 6 77 24 21 21 19 25 139
Paula Coccia Argentina 7 79 1.0× 23 1.0× 27 1.3× 26 1.2× 11 0.6× 20 177
Gloria Ashuntantang Cameroon 8 91 1.2× 6 0.3× 17 0.8× 13 0.6× 19 1.0× 25 203
Yannick Mayamba Nlandu Democratic Republic of the Congo 7 86 1.1× 8 0.3× 14 0.7× 7 0.3× 29 1.5× 33 168
Khalid Bashir United States 7 61 0.8× 3 0.1× 43 2.0× 18 0.9× 13 0.7× 31 192
Sanjay Ramakrishnan United Kingdom 9 54 0.7× 8 0.3× 5 0.2× 34 1.6× 25 1.3× 24 379
Chanel Prestidge New Zealand 8 53 0.7× 32 1.3× 4 0.2× 9 0.4× 7 0.4× 19 215
M. Campanini Italy 6 20 0.3× 9 0.4× 18 0.9× 10 0.5× 6 0.3× 31 126
Guillermo Martín-Reyes Spain 4 97 1.3× 18 0.8× 13 0.6× 37 1.8× 2 0.1× 12 134
Sofia Santos Portugal 8 21 0.3× 13 0.5× 5 0.2× 9 0.4× 8 0.4× 28 129
Mohamed Hassan United Arab Emirates 7 50 0.6× 4 0.2× 14 0.7× 15 0.7× 10 0.5× 20 122

Countries citing papers authored by Edita Žiginskienė

Since Specialization
Citations

This map shows the geographic impact of Edita Žiginskienė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edita Žiginskienė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edita Žiginskienė more than expected).

Fields of papers citing papers by Edita Žiginskienė

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edita Žiginskienė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edita Žiginskienė. The network helps show where Edita Žiginskienė may publish in the future.

Co-authorship network of co-authors of Edita Žiginskienė

This figure shows the co-authorship network connecting the top 25 collaborators of Edita Žiginskienė. A scholar is included among the top collaborators of Edita Žiginskienė based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edita Žiginskienė. Edita Žiginskienė is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrulienė, Kristina, et al.. (2024). Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients. Microorganisms. 12(5). 861–861. 1 indexed citations
2.
Šitkauskienė, Brigita, Inga Arūnė Bumblytė, Edita Žiginskienė, et al.. (2021). Immune Response after SARS-CoV-2 Vaccination in Kidney Transplant Patients. Medicina. 57(12). 1327–1327. 12 indexed citations
4.
Petrulienė, Kristina, et al.. (2021). Mortality Prediction in Patients with Severe Acute Kidney Injury Requiring Renal Replacement Therapy. Medicina. 57(10). 1076–1076. 5 indexed citations
5.
Žiginskienė, Edita, et al.. (2018). Associations of vascular calcification, calcium phosphate disturbances, FGF 23 and Matrix Gla protein with mortality of hemodialysis patients: one center cohort study. Revista română de medicină de laborator. 26(4). 451–460. 2 indexed citations
6.
Žvirblytė, Rūta, et al.. (2018). Changes of Left and Right Ventricle Mechanics and Function in Patients with End-Stage Renal Disease Undergoing Haemodialysis. Medicina. 54(5). 87–87. 18 indexed citations
7.
Petrulienė, Kristina, et al.. (2017). Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Medicina. 53(2). 90–100. 21 indexed citations
8.
Adukauskienė, Dalia, et al.. (2017). Mortality prediction in patients with acute kidney injury requiring renal replacement therapy after cardiac surgery. Medicina. 53(4). 217–223. 11 indexed citations
9.
Žiginskienė, Edita, et al.. (2016). Changes of etiology, incidence and outcomes of severe acute kidney injury during a 12-year period (2001–2012) in large university hospital. Néphrologie & Thérapeutique. 12(6). 448–453. 4 indexed citations
10.
Bumblytė, Inga Arūnė, et al.. (2016). Association between vascular calcification assessed by simple radiography and non-fatal cardiovascular events in hemodialysis patients. Néphrologie & Thérapeutique. 12(7). 503–507. 4 indexed citations
11.
Žiginskienė, Edita, et al.. (2013). Renal Anemia Control in Lithuania: Influence of Local Conditions and Local Guidelines. The Scientific World JOURNAL. 2013(1). 260915–260915. 2 indexed citations
12.
Žiginskienė, Edita, et al.. (2011). Adherence to treatment and hospitalization risk in hemodialysis patients. Journal of Nephrology. 25(5). 672–678. 17 indexed citations
13.
Žiginskienė, Edita, et al.. (2010). Vascular access for hemodialysis: creation, functioning, and complications (Data of the Hospital of Kaunas University of Medicine). Medicina. 46(8). 550–550. 2 indexed citations
14.
Žiginskienė, Edita, et al.. (2010). Risk factors for cardiovascular hospitalization in hemodialysis patients. Medicina. 46(8). 544–544. 1 indexed citations
15.
Stankuvienė, Asta, et al.. (2010). Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005. Medicina. 46(8). 516–516. 28 indexed citations
16.
Žiginskienė, Edita, et al.. (2007). Hemodializės tarnybos ir inkstų transplantacijos raidos paralelės Lietuvoje (1996–2005). Laba (Lietuvos akademinių bibliotekų direktorių asociacija). 43. 114–120.
17.
Žiginskienė, Edita, et al.. (2007). [Changes in hemodialysis adequacy in Lithuania during 1999-2005].. PubMed. 43 Suppl 1. 52–7.
18.
Žiginskienė, Edita, et al.. (2005). [Development of hemodialysis service in Lithuania during (1996-2003)].. PubMed. 41 Suppl 1. 31–7. 1 indexed citations
19.
Žiginskienė, Edita, et al.. (2005). A registry of haemodialysis patients and the progress of haemodialysis services in Lithuania. Nephrology Dialysis Transplantation. 20(12). 2623–2628. 3 indexed citations
20.
Žiginskienė, Edita, et al.. (2003). [Relationship between lethality of hemodialysis patients, erythropoietin dosage for renal anemia treatment and hemodialysis quality].. PubMed. 39 Suppl 1. 119–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026